(RGEN) Delayed Nasdaq - 04:00:00 2023-02-22 pm EST 169.98 USD -4.51% 05:05p REPLIGEN CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) AQ 08:30a Transcript : Repligen Corporation, Q4 2022 Earnings Call, Feb 22, 2023 CI 08:04a Repligen Q4 Adjusted Earnings Drops, Revenue Gains; Issues 2023 Outlook MT Summary Quotes Charts News Ratings Calendar Company Financials Consensus Revisions Funds Summary Most relevant All News Analyst Reco.